Cargando…
Current and future direction in treatment of HPV-related cervical disease
Human papillomavirus (HPV) is the most common sexually transmitted virus in the world. About 70% of cervical cancers are caused by the most oncogenic HPV genotypes of 16 and 18. Since available prophylactic vaccines do not induce immunity in those with established HPV infections, the development of...
Autores principales: | Khairkhah, Niloofar, Bolhassani, Azam, Najafipour, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045016/ https://www.ncbi.nlm.nih.gov/pubmed/35478255 http://dx.doi.org/10.1007/s00109-022-02199-y |
Ejemplares similares
-
Application of Cell Penetrating Peptides as a Promising Drug Carrier to Combat Viral Infections
por: Khairkhah, Niloofar, et al.
Publicado: (2023) -
Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis
por: Khairkhah, Niloofar, et al.
Publicado: (2020) -
Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen
por: Khairkhah, Niloofar, et al.
Publicado: (2022) -
Kidney organoids: current knowledge and future directions
por: Khoshdel-Rad, Niloofar, et al.
Publicado: (2022) -
The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research
por: Bratcher, Lara F, et al.
Publicado: (2010)